Amplitude Ventures

Amplitude Ventures is a Canadian venture capital firm specializing in precision medicine, focusing on the integration of biology and artificial intelligence to develop innovative healthcare solutions. The firm operates with a unique growth model, building companies with world-class management teams and scaling them to breakout potential. With over $500 million in assets under management and offices in Montreal, Toronto, and Vancouver, Amplitude Ventures applies a proven, evidence-based approach to investing in leading precision medicine companies.

The firm's investment strategy encompasses various stages, including Pre-Seed, Seed, Series A, Series B, Growth, Late Stage, and Pre-IPO, with a geographical focus on Canada and the United States. Amplitude Ventures has a diverse portfolio in industries such as Biotechnology, Healthcare, and Artificial Intelligence. Notable investments include Repare Therapeutics, Abdera, Congruence, Radiant, and Valence, the latter acquired by Recursion. The firm's second fund, closed in May 2024 with $263 million (US$192 million), enables continued support for entrepreneurs and innovators in the precision medicine sector.

Amplitude Ventures is committed to the success of founders, patients, and investors, regularly partnering with leading entrepreneurs to positively impact the patient journey. The firm's team comprises entrepreneurs and scientists who value excellence, transparency, and integrity, fostering partnerships with passionate founders and innovators. Their approach has resulted in over $1 billion in company value, reflecting their dedication to advancing healthcare through precision medicine and AI integration.